Cargando…
Clinical development of placental malaria vaccines and immunoassays harmonization: a workshop report
Placental malaria caused by Plasmodium falciparum infection constitutes a major health problem manifesting as severe disease and anaemia in the mother, impaired fetal development, low birth weight or spontaneous abortion. Prevention of placental malaria currently relies on two key strategies that ar...
Autores principales: | Chêne, Arnaud, Houard, Sophie, Nielsen, Morten A., Hundt, Sophia, D’Alessio, Flavia, Sirima, Sodiomon B., Luty, Adrian J. F., Duffy, Patrick, Leroy, Odile, Gamain, Benoit, Viebig, Nicola K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027113/ https://www.ncbi.nlm.nih.gov/pubmed/27639691 http://dx.doi.org/10.1186/s12936-016-1527-8 |
Ejemplares similares
-
Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development
por: Chêne, Arnaud, et al.
Publicado: (2018) -
Preclinical immunogenicity and safety of the cGMP-grade placental malaria vaccine PRIMVAC
por: Chêne, Arnaud, et al.
Publicado: (2019) -
Progress and Insights Toward an Effective Placental Malaria Vaccine
por: Gamain, Benoît, et al.
Publicado: (2021) -
Workshop report: Immunoassay standardisation for “universal” influenza vaccines
por: Pavlova, Sophia, et al.
Publicado: (2017) -
VAR2CSA-Mediated Host Defense Evasion of Plasmodium falciparum Infected Erythrocytes in Placental Malaria
por: Tomlinson, Alice, et al.
Publicado: (2021)